← Open Payments lookup

AILA SOOMRO: Open Payments

NPI 1851949804 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,317 in 29 payments from 12 companies in 2025. Trend: 2023 $412 · 2024 $664 · 2025 $1,317

Food & beverage: $1,317
CompanyPaymentsAmount
AOP Health US, LLC1$600
PFIZER INC.4$118
Aimmune Therapeutics, Inc.4$103
ABBVIE INC.3$93
Alexion Pharmaceuticals, Inc.3$80
Salix Pharmaceuticals, a division of Bausch Health US, LLC4$76
CSL Behring2$65
Boehringer Ingelheim Pharmaceuticals, Inc.3$52
VERTEX PHARMACEUTICALS INCORPORATED2$39
Ferring Pharmaceuticals Inc.1$36

Products named: Rapiblyk, VYNDAQEL, VOWST, DALVANCE, ULTOMIRIS, XIFAXAN, Kcentra, JARDIANCE.

Industry payments across TX — which companies pay providers there.